Cited by 101Diet and metabolism studiesDietary Effects on HealthNutritional Studies and Diet

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 7 of the 51 sources its claims cite were checked for support.

Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials

Open access

Abstract

Background: Systematic reviews and meta-analyses of randomized clinical trials (RCTs) have reported the benefits of ketogenic diets (KD) in various participants such as patients with epilepsy and adults with overweight or obesity . Nevertheless, there has been little synthesis of the strength and quality of this evidence in aggregate. Methods: To grade the evidence from published meta-analyses of RCTs that assessed the association of KD, ketogenic low-carbohydrate high-fat diet (K-LCHF), and very low-calorie KD (VLCKD) with health outcomes, PubMed, EMBASE, Epistemonikos, and Cochrane database of systematic reviews were searched up to February 15, 2023. Meta-analyses of RCTs of KD were included. Meta-analyses were re-performed using a random-effects model. The quality of evidence per association provided in meta-analyses was rated by the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) criteria as high, moderate, low, and very low. Results: We included 17 meta-analyses comprising 68 RCTs (median [interquartile range, IQR] sample size of 42 [20–104] participants and follow-up period of 13 [8–36] weeks) and 115 unique associations. There were 51 statistically significant associations (44%) of which four associations were supported by high-quality evidence (reduced triglyceride ( n = 2), seizure frequency ( n = 1) and increased low-density lipoprotein cholesterol (LDL-C) ( n = 1)) and four associations supported by moderate-quality evidence (decrease in body weight, respiratory exchange ratio (RER), hemoglobin A 1c , and increased total cholesterol). The remaining associations were supported by very low (26 associations) to low (17 associations) quality evidence. In overweight or obese adults, VLCKD was significantly associated with improvement in anthropometric and cardiometabolic outcomes without worsening muscle mass, LDL-C, and total cholesterol. K-LCHF was associated with reduced body weight and body fat percentage, but also reduced muscle mass in healthy participants. Conclusions: This umbrella review found beneficial associations of KD supported by moderate to high-quality evidence on seizure and several cardiometabolic parameters. However, KD was associated with a clinically meaningful increase in LDL-C. Clinical trials with long-term follow-up are warranted to investigate whether the short-term effects of KD will translate to beneficial effects on clinical outcomes such as cardiovascular events and mortality.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This umbrella review of 17 meta-analyses covering 68 RCTs and 115 unique associations found that ketogenic diets have beneficial associations supported by moderate- to high-quality evidence for seizure frequency and several cardiometabolic parameters, but also a clinically meaningful increase in LDL-C. Long-term trials are needed to determine whether short-term benefits translate into improved clinical outcomes such as cardiovascular events and mortality.

Key findings

  • Among 115 unique associations, 51 (44%) were statistically significant; only 4 were supported by high-quality evidence: reduced triglyceride in adults with T2DM at 3 months (MD −18.36 mg/dL; 95% CI −24.24 to −12.49) and 12 months (MD −24.10 mg/dL; 95% CI −33.93 to −14.27), increased LDL-C at 12 months (MD 6.35 mg/dL; 95% CI 2.02 to 10.69), and seizure frequency reduction ≥50% from baseline in children/adolescents with refractory epilepsy (RR 5.11; 95% CI 3.18 to 8.21).
  • Four statistically significant associations were supported by moderate-quality evidence: reduced HbA1c (MD −0.61%; 95% CI −0.82 to −0.40), reduced body weight with VLCKD (MD −9.33 kg; 95% CI −15.45 to −3.22), reduced respiratory exchange ratio with K-LCHF in athletes (SMD −2.66; 95% CI −3.77 to −1.54), and increased total cholesterol with K-LCHF in athletes (MD 1.32 mg/dL; 95% CI 0.64 to 1.99).
  • In healthy participants, K-LCHF for 3–12 weeks reduced body weight by 3.68 kg (95% CI −4.45 to −2.90) but also reduced muscle mass by 1.27 kg (95% CI −1.83 to −0.70; MCID threshold 1.10 kg). In overweight or obese adults, VLCKD improved anthropometric and cardiometabolic outcomes without worsening muscle mass, LDL-C, or total cholesterol.
  • Most associations were rated very low (66/115, 57%) or low (36/115, 31%) quality; among statistically significant associations, 26 were very low, 17 low, 4 moderate, and 4 high quality.

Methods

  • Umbrella review of published meta-analyses of RCTs assessing any type of ketogenic diet (KD, K-LCHF, VLCKD, MAD) against any comparator for any health outcome; PubMed, EMBASE, Epistemonikos, and Cochrane Database of Systematic Reviews were searched from inception to February 15, 2023.
  • Included 17 meta-analyses comprising 68 unique RCTs (median [IQR] sample size 42 [20–104] participants; median follow-up 13 [8–36] weeks) and 115 unique associations.
  • Meta-analyses were re-performed using random-effects models; evidence per association was graded with GRADE, meta-analysis quality with AMSTAR-2, and sensitivity analyses excluded small studies (<25th percentile) and high-risk-of-bias RCTs.

Limitations

  • Stated: the review was confined to published meta-analyses, so outcomes and populations not covered by existing meta-analyses could not be assessed; most included meta-analyses were rated AMSTAR-2 critically low confidence; dose–response analysis was not possible due to insufficient carbohydrate intake details; most RCTs had small samples and short follow-up; adherence likely decreased and carbohydrate intake increased over trials, so the precise degree of ketosis contributing to benefits is uncertain.
  • Evident from the text: most associations were downgraded because of serious imprecision, large heterogeneity, and indirectness from mixed interventions and comparators; most outcomes were surrogate measures, and RCTs were limited to selected populations such as overweight/obesity, T2DM, cancer, athletes, and refractory epilepsy.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12916-023-02874-y

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Study selection flow of meta-analyses. Abbreviation: CDSR, Cochrane database of systematic review
Fig. 1 Study selection flow of meta-analyses. Abbreviation: CDSR, Cochrane database of systematic reviewCC BY · PubMed Central
Fig. 2 Associations of Types of Ketogenic Diet with Health Outcomes. Abbreviations: BMI, body mass index, DBP, diastolic blood pressure; GRADE, Grading of Recommendations, Assessment, Development, and Evaluations; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model of insulin resistance; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TEI, total energy intake
Fig. 2 Associations of Types of Ketogenic Diet with Health Outcomes. Abbreviations: BMI, body mass index, DBP, diastolic blood pressure; GRADE, Grading of Recommendations, Assessment, Development, and Evaluations; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model of insulin resistance; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TEI, total energy intakeCC BY · PubMed Central

Verification

Claims the paper makes

25 Own result · 20 Not checked yet · 10 Own method · 7 No basis given · 4 Own interpretation · 2 Partly supported · 1 Mixed support · accuracy not yet measured

Verify all 44 references — free account

Show all 40 claims

  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 16
29 of 29
  • The paper relies on this without support.

    There has been little synthesis of the strength and quality of evidence from meta-analyses of RCTs of KD in aggregate.

    “Nevertheless, there has been little synthesis of the strength and quality of this evidence in aggregate.”
    “To date, there has been little synthesis of the strength and quality of this evidence in aggregate.”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Cited by

Sorted by citations

See all 101

Metadata

Authors
Patikorn, C., Saidoung, P., Pham, T., Phisalprapa, P., Lee, Y. Y., Varady, K. A., Veettil, S. K., & Chaiyakunapruk, N.
Affiliations
  • Chulalongkorn University (TH)
  • University of Utah (US)
  • Siriraj Hospital (TH)
  • Universiti Sains Malaysia (MY)
  • University of Illinois Chicago (US)
Corresponding author
  • Veettil, Sajesh K.
  • Chaiyakunapruk, Nathorn
Venue
BMC Medicine
Published
2023-05-25
Volume
21
Issue
1
Pages
196-196
ISSN
1741-7015 (ISSN-L)
OpenAlex
W4378220711
Cited by
101
References
68
Citations by year
2026: 28 · 2025: 30 · 2024: 33 · 2023: 10
FWCI
17.79
Type
journal article
Language
en
Open access
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
ketogenic diet, very low-calorie ketogenic diet, epilepsy, seizure frequency, cardiometabolic outcomes, LDL cholesterol, triglycerides, body weight, body fat percentage, muscle mass, quality of evidence, GRADE, obesity, overweight adults, health outcomes, respiratory exchange ratio
MeSH terms
Adult, Body Weight, Cardiovascular Diseases, Humans, Cholesterol, LDL, Obesity, Seizures, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Overweight, Diet, Ketogenic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review